Skip to main content

Animations

MJFF Publications

8561 - 8570 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2017
  • 2016
  • 2022
  • 2017
  • 2025
  • 2020
  • 2025
  • 2017
  • 2015
  • Summary Details
    OPEN
    Title: Il-10 signaling reduces survival in mouse models of synucleinopathy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00169-8
    Citation Count: 12
  • Summary Details
    OPEN
    Title: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0456-2
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Increased 5-hydroxymethylation levels in the sub ventricular zone of the Alzheimer's brain
    Journal Name: Neuroepigenetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nepig.2016.04.002
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Serine/Threonine Protein Phosphatase 2A Regulates the Transport of Axonal Mitochondria
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2022.852245
    Citation Count: 5
  • Summary Details
    OPEN
    Title: An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways
    Journal Name: Molecular & Cellular Proteomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1074/mcp.m116.061440
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian Monkeys
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30280
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.27989
    Citation Count: 62
  • Summary Details
    RESTRICTED
    Title: Frailty in prodromal Parkinson's disease in Medicare beneficiaries
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107965
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.13223
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2015.11.007
    Citation Count: 122
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.